BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/24/2025 9:30:58 AM | Browse: 1 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Application of modified Charlson comorbidity index for predicting outcomes following adult living donor liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Gowtham Rajan, Amal Francis Sam, Akila Rajakumar, Dinesh Jothimani and Mohamed Rela |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Akila Rajakumar, FRCA, Head, MD, Department of Liver Transplant Anaesthesia and Intensive Care, Institute of Liver Disease and Transplantation, Dr. Rela Institute, No. 7 CLC Works Road, Chennai 600044, Tamil Nadu, India. drakila.rajakumar@gmail.com |
| Key Words |
Charlson comorbidity index; Post living donor liver transplantation outcomes; Composite outcome scores in living donor liver transplantation; Charlson comorbidity index vs model for end-stage liver disease; Modified Charlson comorbidity index in liver transplantation; Outcome prediction in living donor liver transplantation |
| Core Tip |
With advances in surgical techniques and perioperative care, the outcomes of liver transplantation have improved significantly encouraging its use in more elderly patients and those with more comorbidities. In addition to severity of liver disease, understanding the impact of extra hepatic comorbidities on the outcomes will help ion prognostication and risk stratification with appropriate resource planning. Charlson comorbidity index has been validated as a good predictor of long-term survival in varied clinical populations. With limited studies regarding its use in liver transplant patients, we attempted to study its applicability in our cohort of living donor liver transplant patients. |
| Citation |
Rajan G, Sam AF, Rajakumar A, Jothimani D, Rela M. Application of modified Charlson comorbidity index for predicting outcomes following adult living donor liver transplantation. World J Hepatol 2025; In press |
 |
Received |
|
2025-07-08 05:35 |
 |
Peer-Review Started |
|
2025-07-08 05:35 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-08-08 08:43 |
 |
Revised |
|
2025-08-29 09:45 |
 |
Second Decision |
|
2025-11-24 02:46 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-11-24 09:30 |
 |
Articles in Press |
|
2025-11-24 09:30 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345